Should we expect an increase of about 120,000 annual deaths? Is this considered the “new normal”?

uesday’s ONS figures (tomorrow around 10AM) will show if we still have infamous (major increase of about 20%) excess mortality/death levels. So far every week (for this year) looks rather bad; so far…

Official government data:

Deaths by 6 Jan 2023 14,983 compared to 10,955 in 2019
Deaths by 13 Jan 2023 17,381 compared to 12,609 in 2019
Deaths by 20 Jan 2023 15,804 compared to 11,860 in 2019
Deaths by 27 Jan 2023 14,137 compared to 11,740 in 2019
Deaths by 3 Feb 2023 13,412 compared to 11,297 in 2019
Deaths by 10 Feb 2023 12,672 compared to 11,660 in 2019
Deaths by 17 Feb 2023 12,031 compared to 11,824 in 2019
Deaths by 24 Feb 2023 11,952 compared to 11,295 in 2019
Deaths by 3 Mar 2023 12,049 compared to 11,044 in 2019

2019 total: 104,284 (first 9 weeks alone)
2023 total: 124,421 (first 9 weeks alone)

That’s an increase of more than 20,000.

New (but not in the mainstream media, just in scientific literature)

• Vaccine brain injury – Invidious
• A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19″>A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19

Description reproduced in case Google censors his videos again:

Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19, (1 October 2022)

www.mdpi.com/2076-393X/10/10/1651

76-year-old man with Parkinson’s disease

Died three weeks after third COVID-19 vaccination

May 2021, ChAdOx1 vaccine

July 2021, Pfizer vaccine

December 2021, Pfizer vaccine

Family of the deceased requested an autopsy,

due to ambiguous clinical signs before death.

PD was confirmed by post-mortem examinations.

Signs of aspiration pneumonia and systemic arteriosclerosis

Histopathological analyses of the brain

Acute vasculitis (predominantly lymphocytic)

Multifocal necrotizing encephalitis

Pronounced inflammation

Glial and lymphocytic reaction

In the heart

Signs of chronic cardiomyopathy

Mild acute lympho-histiocytic myocarditis and vasculitis

Patient had no history of COVID-19

Immunohistochemistry for SARS-CoV-2 antigens (spike and nucleocapsid proteins) was performed.

Only spike protein but no nucleocapsid protein could be detected,

within the foci of inflammation, brain and heart

Spike protein detected in the endothelial cells of small blood vessels.

Quotes from the paper

Since no nucleocapsid protein could be detected, the presence of spike protein must be ascribed to vaccination rather than to viral infection.

The findings corroborate previous reports of encephalitis and myocarditis caused by gene-based COVID-19 vaccines.

A causal connection of these findings to the preceding COVID-19 vaccination was established by immunohistochemical demonstration of SARS-CoV-2 spike protein.

The methodology introduced in this study should be useful for distinguishing between causation by COVID-19 vaccination or infection in ambiguous cases.

Clinicians should take note of such case reports for the sake of early detection and management of such adverse events among their patients.

A thorough post-mortem examination of deaths in connection with COVID-19 vaccination should be considered in ambiguous circumstances, including histology.

Clinical History

First vaccination in May 2021 (ChAdOx1)

He experienced pronounced cardiovascular side effects

After the second vaccination in July 2021 (BNT162b2)

Family noted obvious behavioral and psychological changes (e.g., he did not want to be touched, anxiety, lethargy, social withdrawal)

Striking worsening of his PD symptoms

2 weeks after the third vaccination

Suddenly collapsed

Collapsed again 2 weeks after, died shortly thereafter

Clinical diagnosis was death due to aspiration pneumonia.

HAVE just grabbed the latest data, which was published 20 minutes ago. Be careful not to read government spin or ONS’s attempt to ‘editorialise’ this data, basically comparing peak pandemic years to the present instead of pre-pandemic times. Here are the numbers of deaths for 2019:

Compare to 2023:

That’s an increase by 29.51% or 30% if you round it up.

Here is the official data:

• ONS data for 2023
• ONS data for 2019

It’s hard to trust the government on such stuff because it was complicit in a botched reponse and would rather cover up not just what happened in the past but what is happening at present.

arah Caul’s (ONS) latest update is rather misleading. It says: “In the week ending 27 January 2023 (Week 4), 14,137 deaths were registered in England and Wales; 579 of these deaths mentioned “novel coronavirus (COVID-19)”, accounting for 4.1% of all deaths.”

They then try to present it a) as a decline (compared to winter’s peak, not compared to prior years) and b) nothing to do with COVID-19.

Comparing this data to pre-COVID-19 levels, we actually see an increase of 20.41%.

Nice “end of pandemic” you got there… I’ve not compared by age groups, but if prior weeks’ data can be considered something to judge by, this impacts all age groups. Not good.

am now satisfied that ONS did not tinker with the mortality data. That’s a relief.

Yesterday I wrote about the latest correspondence with ONS. The latest explanation from Anne suggests we were talking about different sheets. In her own words:

Good afternoon, Dr Schestowitz

Thank you for your response.

I have utilised the previous versions tab of the Deaths Registered weekly set to look through this enquiry.

As I explained in the previous email, the undercount affected death occurrences not registrations. Death registrations use the date of death registrations, whereas occurrences use date of death.

This is a screen shot of sheet 1 (Weekly provisional death registrations in England and Wales) published for week 49. Sheet 2 (weekly provisional death registrations by sex and age in England and Wales) also uses death registrations.

On the previous versions tab this is week 49 when you download the excel spreadsheet published 20^th December. I have used an arrow to denote the publishing week at the top of the screenshot.

There is no week 50 dataset due to the festive period, therefore week 51 contains both week 50 and week 51 data.

This version of Sheet 1 (registrations) was superseded with week 50 and 51 data on 5^th January 2023. As you rightly point out there is no change to the registration data for week 49, this is because the undercount did not affect death registrations.

However, on Sheet 11 which uses death occurrences (date of death) we published 10,565 death occurrences in week 49 on the 20^th December with a note explaining the undercount was due to a processing error.

With the next publication on 5^th January, publishing week 50 and 51 data we corrected the undercount and published 12,109 death occurrences for week 49.

The majority of worksheets within weekly death publication use Registration data, which is why the update in week 51 may not have been overtly visible.

I hope this answers your question and please let me know if I can be of any further assistance.

Kind regards

Anne

“Thank you, Anne,” I said. “That’s a very detailed and satisfactory explanation. I will use it to relay a clarification on what happened and why there’s no reason to doubt the accuracy of this data. PS – the work you do is very important at this time.”

New video:

Description:

US, Weekly Cumulative All-Cause Excess Deaths

https://www.usmortality.com

https://www.usmortality.com/deaths/excess-cumulative/united-states

Excess deaths 2022 (Up to December 1st) 242,224

https://www150.statcan.gc.ca/n1/pub/71-607-x/71-607-x2021028-eng.htm

https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3233

Australian Bureau of Statistics

Provisional Mortality Statistics

Reference period, Jan – Sep 2022

144,650 deaths that occurred by 30 September

19,986 (16.0%) more than the historical average.

Deaths attributed to covid, 8,160

October covid deaths, 232

Australia, September 2022

13,675 deaths (doctor certified)

1,814 were coroner referred.

UK, ONS

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections

UK Prevalence

2.61% in England (1 in 40 people)

3.94% in Wales (1 in 25 people)

4.22% in Northern Ireland (1 in 25 people)

3.26% in Scotland (1 in 30 people)

Deaths and excess deaths (W/E week 13th January 2023)

A total of 19,916 deaths were registered in the UK

20.4% above the five-year average.

Covid UK deaths

1,059 deaths involving COVID-19 registered

(up 842 on the week)

Deaths involving COVID-19 accounted for 5.3% of all deaths

UK, Office for Health Improvement

https://www.gov.uk/government/statistics/excess-mortality-in-england-and-english-regions

Excess deaths in all age groups, (0 to 24 years)
UK, Institute and Faculty of Actuaries

https://actuaries.org.uk/news-and-media-releases/news-articles/2023/jan/17-january-23-cmi-says-2022-had-the-worst-second-half-for-mortality-since-2010/

Mortality rates in 2022 compare to 2019 at different ages

2022, mortality, 7.8% higher for ages 20-44

In the UK, the second half of 2022

26,300 excess deaths,

compared to 4,700 in the first half of 2022

Europe, EuroMOMO, Bulletin week 2 2023

https://www.euromomo.eu

Pooled EuroMOMO, all-cause mortalit

Elevated level of excess mortality,

overall and in all age groups.

Data from 25 European countries or subnational regions

Average levels from pre 2020

https://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/mortality-data-and-stats

https://www.stats.govt.nz/topics/births-and-deaths

Year ended September 2021, total of 34,578 deaths

Year ended September 2022, total of 38,052 deaths

New video:

Description: (for backup; Google censors his videos sometimes)

JCVI makes interim recommendations to government on the COVID-19 vaccination programme for 2023.

https://www.gov.uk/government/news/jcvi-advises-an-autumn-covid-19-vaccine-booster

https://www.gov.uk/government/collections/covid-19-vaccination-programme

Joint Committee on Vaccination and Immunisation (JCVI)

has advised that plans should be made for those at higher risk of severe COVID-19 to be offered a booster vaccination this autumn (2023).

Professor Wei Shen Lim, Chair of COVID-19 vaccination on the JCVI

As the transition continues away from a pandemic emergency response towards pandemic recovery,

In England, the closure of the autumn booster campaign and the first booster offer will be on 12 February 2023.

(basically no more boosters for healthy under 50s)

Similarly, the JCVI is advising that the primary course COVID-19 vaccination should move,

over the course of 2023, towards a more targeted offer

Coronavirus (COVID-19) vaccine

https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/

Everyone aged 5 (on or before 31 August 2022) and over can get a 1st and 2nd dose of the COVID-19 vaccine.

https://www.sst.dk/en/English/Corona-eng/Vaccination-against-COVID-19

we recommend vaccination of people aged 50 years and over as well as selected risk groups.

Regulator funding

https://www.bmj.com/content/377/bmj.o1538

Industry money saturates the globe’s leading regulators.